ACRS Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues NUVB Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid PreRevenue Stage Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline FCPT Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher MU Q1 2026 Earnings Stellar EPS Beat Drives Stock Surge EPR Properties Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Experiential Demand